AnnWildGramzaMD

Oncology • Washington, DC

Hematologic Oncology

Physician

Join to view full profile

Dr. Gramza is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gramza's full profile

Already have an account?

Office
3800 Reservoir Rd Nw
Washington, DC 20007
Phone+1 202-444-2223
Is this information wrong?

Education & Training

Oregon Health & Science UniversityFellowship, Hematology and Medical Oncology, 2004 - 2007
University of New Mexico School of MedicineResidency, Internal Medicine, 2000 - 2003
Ohio State University College of MedicineClass of 2000

Certifications & Licensure

OR State Medical License 2004 - Present
DC State Medical License 2015 - 2024
VA State Medical License 2012 - 2016
NM State Medical License 2003 - 2004

Clinical Trials

A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) Start of enrollment: 2011 Jan 26
Completed
Phase 1, Phase 2

Publications & Presentations

PubMed

12 citations
A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer.
Jaydira Del Rivero, Renee N. Donahue, Jennifer L. Marte, Ann W. Gramza, Marijo Bilusic, Myrna Rauckhorst, Lisa M. Cordes, Maria J. Merino, William L. Dahut, Jeffrey Sc...> ;Frontiers in Endocrinology. 2020 Aug 7
12 citations
Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer
Jaydira Del Rivero, Maureen Edgerly, Jean Ward, Ravi A. Madan, Sanjeeve Balasubramaniam, Tito Fojo, Ann Wild Gramza> ;The Oncologist. 2019 Jan 1
103 citations
Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma.
Julie Ann Sosa, Rossella Elisei, Barbara Jarzab, Jai Balkissoon, Shiao Ping Lu, Chandrasekhar Bal, Shanthi Marur, Ann Wild Gramza, Rami Ben Yosef, Barbara J. Gitlitz, ...> ;Thyroid. 2014 Feb 11
79 citations
Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial
Robert C. Smallridge, John A. Copland, Marcia S. Brose, J. T. Wadsworth, Yariv Houvras, Michael E. Menefee, Keith C. Bible, Manisha H. Shah, Ann Wild Gramza, Joshua P....> ;The Journal of Clinical Endocrinology and Metabolism. 2013 Apr 15
30 citations
Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer
Julie Ann Sosa, Jai Balkissoon, Shiao Ping Lu, Peter Langecker, Rossella Elisei, Barbara Jarzab, Chandrasekhar Bal, Shanthi Marur, Ann Wild Gramza, Frank G. Ondrey> ;Surgery. 2012 Dec 1
160 citations
Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors
Ann W. Gramza, Christopher L. Corless, Michael Heinrich> ;Clinical Cancer Research. 2009 Dec 15
2 citations
Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management
Ann W. Gramza, Kathryn G. Schuff> ;Oncotargets and Therapy. 2009 Jan 1
Join now to see all

Press Mentions

Impact of Drug, Genomic Innovations on Thyroid Cancer TreatmentJune 30th, 2016

Hospital Affiliations

MedStar Georgetown University HospitalWashington, District of Columbia

AnnWildGramzaMD

Dr. Gramza is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.